Quarterly report pursuant to Section 13 or 15(d)

Consolidated Balance Sheets (Unaudited)

v3.23.3
Consolidated Balance Sheets (Unaudited) - USD ($)
$ in Thousands
Sep. 30, 2023
Dec. 31, 2022
Current assets:    
Cash and cash equivalents $ 129 $ 112
Restricted cash 111 111
Deferred course expenses 200 163
Prepaid expenses and other current assets 362 342
Inventory 1 1
Discontinued operations current assets
Total current assets 803 729
Property and equipment, net 1
Right-of-use assets 78 113
Other assets 6 6
Discontinued operations-other assets 32 32
Total assets 920 880
Current liabilities:    
Accounts payable 2,658 2,577
Royalties payable 110 110
Accrued course expenses 240 237
Accrued salaries, wages and benefits 743 195
Operating lease liability, current portion 59 67
Other accrued expenses 4,029 2,940
Deferred revenue 3,861 3,470
Short-term related party debt, net of unamortized debt discount of $133 3,707 2,429
Current portion of long term debt, net of unamortized debt discount of $0 1,001 1,184
Discontinued operations-current liabilities 9,442 9,243
Total current liabilities 25,850 22,452
Long-term debt, net of current portion and net of unamortized debt discount 758 558
Deferred tax liability, net 796 796
Other long term liabilities
Operating lease liability, net of current portion 18 46
Total liabilities 27,423 23,852
Commitments and contingencies (Note 13)
Stockholders’ deficit:    
Preferred stock, $0.0001 par value, 20,000,000 shares authorized, none issued
Common stock, $0.0001 par value; 200,000,000 authorized; 48,382,697 and 38,182,697 shares issued and outstanding as of September 30, 2023 and December 31, 2022 3 3
Additional paid-in capital 13,253 13,217
Cumulative foreign currency translation adjustment 617 1,593
Accumulated deficit (39,993) (37,695)
Non Controlling Interest (383) (91)
Total stockholders’ deficit (26,503) (22,973)
Total liabilities and stockholders’ deficit $ 920 $ 880